The 36-month beta value for AURA is at 0.42. Analysts have varying views on the stock, with 4 analysts rating it as a “buy,” 3 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for AURA is 44.72M, and currently, shorts hold a 4.37% of that float. The average trading volume for AURA on May 09, 2025 was 269.15K shares.
AURA) stock’s latest price update
Aura Biosciences Inc (NASDAQ: AURA) has experienced a rise in its stock price by 16.70 compared to its previous closing price of 4.97. However, the company has seen a fall of -4.45% in its stock price over the last five trading days. globenewswire.com reported 2025-05-01 that BOSTON, May 01, 2025 (GLOBE NEWSWIRE) — Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced that members of its senior management team will participate in the following upcoming investor conferences:
AURA’s Market Performance
Aura Biosciences Inc (AURA) has experienced a -4.45% fall in stock performance for the past week, with a 10.90% rise in the past month, and a -27.59% drop in the past quarter. The volatility ratio for the week is 10.18%, and the volatility levels for the past 30 days are at 8.24% for AURA. The simple moving average for the past 20 days is 4.25% for AURA’s stock, with a -28.99% simple moving average for the past 200 days.
Analysts’ Opinion of AURA
Many brokerage firms have already submitted their reports for AURA stocks, with H.C. Wainwright repeating the rating for AURA by listing it as a “Buy.” The predicted price for AURA in the upcoming period, according to H.C. Wainwright is $21 based on the research report published on July 25, 2024 of the previous year 2024.
BTIG Research gave a rating of “Buy” to AURA, setting the target price at $38 in the report published on April 17th of the previous year.
AURA Trading at -7.74% from the 50-Day Moving Average
After a stumble in the market that brought AURA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -53.14% of loss for the given period.
Volatility was left at 8.24%, however, over the last 30 days, the volatility rate increased by 10.18%, as shares surge +8.21% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -22.67% lower at present.
During the last 5 trading sessions, AURA fell by -4.45%, which changed the moving average for the period of 200-days by -36.61% in comparison to the 20-day moving average, which settled at $5.56. In addition, Aura Biosciences Inc saw -29.44% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AURA starting from Elazzouzi Amy, who proposed sale 897 shares at the price of $5.49 back on Apr 16 ’25. After this action, Elazzouzi Amy now owns shares of Aura Biosciences Inc, valued at $4,925 using the latest closing price.
Kilroy Conor, the Officer of Aura Biosciences Inc, proposed sale 7,162 shares at $5.49 during a trade that took place back on Apr 16 ’25, which means that Kilroy Conor is holding shares at $39,319 based on the most recent closing price.
Stock Fundamentals for AURA
The total capital return value is set at -0.57. Equity return is now at value -46.01, with -39.73 for asset returns.
Based on Aura Biosciences Inc (AURA), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at -4.25.
Currently, EBITDA for the company is -85.58 million with net debt to EBITDA at 0.14. The liquidity ratio also appears to be rather interesting for investors as it stands at 10.77.
Conclusion
In conclusion, Aura Biosciences Inc (AURA) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
